A total of 98 patients were enrolled. Group 1 consisted in 57 women (58,2%), and Group 2 in 41 (41,8%). Patients’ characteristics, outcomes at FSFI and OAB-screener questionnaires and OAB rate are reported in table 1. Group 2 consisted only in primary POP surgeries, while in Group 1 only 75.5% were surgery naïve for POP. Patients in both groups had pre-operative POP-Q stage III. Pre-operative patients’ characteristics were different for FSFI subdomains, OAB screener, age and recurrent POP. Mean follow up was 64 months (SD 32) and 22,3 months (SD 12,3) in Group 1 and Group 2 respectively. Complications were slightly higher in Group 1, but without a statistically significant difference. In Group 1 there were 6 (10,5%) 5 medical Clavien 2 and one surgical Clavien 2, and in Group 2 there were 3 (7,3%) complications, 2 Medical Clavien 2 and 1 medical Clavien 3. In both groups PGI-I proved a clear patients’ symptoms improvement with good subjective surgery outcomes, without statistically significant differences between them. Mean PGI-I was 1,8 (SD 1,5) in Group 1, while in Group 2 was 1,9 (SD 1,4), p>0.05. Mesh related complications occurred only in 1 (1,7%) patient (vaginal mesh extrusion successfully managed conservatively with Oestrogenic local therapy). OAB-Screener improved after surgery even at long term follow up in both groups (p<0.0001). OAB rate reduced after surgeries in both groups: 5 (45,5%) in Group 1 and 9 (56,3%) in Group 2. De novo OAB were 2 (3,5%) and 2 (4,9%) in Group 1 and Group 2 respectively. In each group, surgery did not significantly influenced FSFI total score, and the comparison between groups did not evidenced any difference (in total score and in sub-domains scores) at follow-up. Analysing the FSFI sub-domains of desire, arousal, satisfaction and pain significantly improved in Group 2. POP recurrence occurred in Group 1 in 2 (3,5%) patients, and in 3 (7,3%) patients of Group 2 (p>0.05).